Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
Shoma HayatAsaduzzaman AsadImran HasanIsrat JahanNowshin PapriZakir Hossain HowladerZhahirul IslamPublished in: Acta neurologica Scandinavica (2022)
NOD variants confer no risk to the susceptibility and severity of GBS. Moreover, NOD2 polymorphism is rare or absent in patients with GBS as well as in the healthy individuals of Bangladesh.